Literature DB >> 10482164

Direct myocardial revascularization and angiogenesis--how many patients might be eligible?

D Mukherjee1, D L Bhatt, M T Roe, V Patel, S G Ellis.   

Abstract

This study examines the proportion of patients with ischemic heart disease who may be candidates for the newer modalities of revascularization. A significant proportion (approximately 5%) of patients who undergo coronary angiography at tertiary referral centers may be eligible for newer methods of therapy.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10482164     DOI： 10.1016/s0002-9149(99)00387-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  32 in total

1.  Percutaneous Myocardial Revascularization.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

Review 2.  Current clinical perspectives on myocardial angiogenesis.

Authors:  Debabrata Mukherjee
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

3.  Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization.

Authors:  Ying Wang; Xiao-Cheng Liu; Jian Zhao; Xiang-Rong Kong; Rong-Fang Shi; Xiao-Bin Zhao; Cun-Xian Song; Tian-Jun Liu; Feng Lu
Journal:  Tex Heart Inst J       Date:  2009

4.  Intramyocardial, autologous CD34+ cell therapy for refractory angina.

Authors:  Douglas W Losordo; Timothy D Henry; Charles Davidson; Joon Sup Lee; Marco A Costa; Theodore Bass; Farrell Mendelsohn; F David Fortuin; Carl J Pepine; Jay H Traverse; David Amrani; Bruce M Ewenstein; Norbert Riedel; Kenneth Story; Kerry Barker; Thomas J Povsic; Robert A Harrington; Richard A Schatz
Journal:  Circ Res       Date:  2011-07-07       Impact factor: 17.367

5.  Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression.

Authors:  W G Marshall; B A Boone; J D Burgos; S I Gografe; M K Baldwin; M L Danielson; M J Larson; D R Caretto; Y Cruz; B Ferraro; L C Heller; K E Ugen; M J Jaroszeski; R Heller
Journal:  Gene Ther       Date:  2009-12-03       Impact factor: 5.250

Review 6.  Effectiveness of percutaneous laser revascularization therapy for refractory angina.

Authors:  Michael McGillion; Allison Cook; J Charles Victor; Sandra Carroll; Julie Weston; Kevin Teoh; Heather M Arthur
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

7.  Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-03-01

Review 8.  Treatment of refractory angina in patients not suitable for revascularization.

Authors:  Timothy D Henry; Daniel Satran; E Marc Jolicoeur
Journal:  Nat Rev Cardiol       Date:  2013-12-24       Impact factor: 32.419

9.  Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials.

Authors:  Rod S Taylor; Jessica De Vries; Eric Buchser; Mike J L Dejongste
Journal:  BMC Cardiovasc Disord       Date:  2009-03-25       Impact factor: 2.298

10.  VEGF gene expression in adult human thymus fat: a correlative study with hypoxic induced factor and cyclooxygenase-2.

Authors:  Francisco Tinahones; Julian Salas; María Dolores Mayas; Adrian Ruiz-Villalba; Manuel Macias-Gonzalez; Lourdes Garrido-Sanchez; Manuel DeMora; Inmaculada Moreno-Santos; Rosa Bernal; Fernando Cardona; Rajaa El Bekay
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.